STMN1 — Stathmin 1
Overview
Mermaid diagram (expand to render)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">STMN1 — Stathmin 1</th>
</tr>
<tr>
<td class="label">Site</td>
<td>Kinase</td>
</tr>
<tr>
<td class="label">Ser16</td>
<td>PKA, CaMKII</td>
</tr>
<tr>
<td class="label">Ser25</td>
<td>CDK1, ERK</td>
</tr>
<tr>
<td class="label">Ser38</td>
<td>MAPK, PKA</td>
</tr>
<tr>
<td class="label">Ser63</td>
<td>PKA, PKC</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Cerebral cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>High</td>
</tr>
<tr>
<td class="label">Substantia nigra</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Dorsal root ganglion</td>
<td>High</td>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">Tubulin</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">MAP2</td>
<td>Mutual regulation</td>
</tr>
<tr>
<td class="label">Tau</td>
<td>Competitive</td>
</tr>
<tr>
<td class="label">Kinesin motors</td>
<td>Indirect</td>
</tr>
<tr>
<td class="label">14-3-3 proteins</td>
<td>Phospho-dependent</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">STMN1</td>
<td>Ubiquitous</td>
</tr>
<tr>
<td class="label">STMN2 (SCG10)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">STMN3 (SCLIP)</td>
<td>Neurons</td>
</tr>
<tr>
<td class="label">STMN4 (RB3)</td>
<td>Brain</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/ms" style="color:#ef9a9a">Ms</a>, <a href="/wiki/tumor" style="color:#ef9a9a">Tumor</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">12 edges</a></td>
</tr>
</table>
STMN1 (Stathmin 1), also known as Oncoprotein 18 (OP18), is a ubiquitous phosphoprotein that plays a critical role in regulating microtubule dynamics. Located on chromosome 1p36.11, the STMN1 gene encodes a 149-amino acid protein (molecular weight ~19 kDa) that functions as a potent microtubule-destabilizing protein. Originally identified as an oncogene overexpressed in various cancers, STMN1 has emerged as a crucial regulator of neuronal function, with significant implications for understanding and treating neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS)[@stathmin2019][@stmn2018].
The central role of STMN1 in microtubule dynamics makes it particularly important in neurons, which rely on sophisticated microtubule networks for intracellular transport, neuronal polarity, synaptic plasticity, and overall cell viability. Dysregulation of STMN1 contributes to microtubule dysfunction, impaired axonal transport, and neuronal death—hallmarks of many neurodegenerative conditions["@microtubule2022"].
Gene and Protein Structure
Gene Organization
The STMN1 gene (Gene ID: 3925) is located on chromosome 1p36.11 and consists of 5 exons spanning approximately 2.5 kb of genomic DNA. The gene produces multiple transcript variants through alternative splicing, though the canonical isoform (149 amino acids) is the predominant form in neurons.
Protein Domain Architecture
The Stathmin 1 protein contains several critical structural features:
N-terminal region (aa 1-50): Contains the core microtubule-destabilizing activity
Stathmin family domain: The signature domain shared among stathmin family members (STMN1-4)
Serine phosphorylation sites: Four serine residues (Ser16, Ser25, Ser38, Ser63) serve as regulatory phosphorylation sites
C-terminal region: Involved in protein-protein interactionsPhosphoregulation
STMN1 activity is tightly regulated by phosphorylation:
Phosphorylation inactivates stathmin's microtubule-destabilizing activity, while dephosphorylation activates it. This allows rapid, signal-dependent control of microtubule dynamics in response to cellular cues[@cassimeris2002].
Normal Physiological Functions
Microtubule Regulation
STMN1 is a master regulator of microtubule dynamics through two primary mechanisms:
Tubulin sequestration: STMN1 binds to free tubulin heterodimers, preventing their incorporation into microtubules
Promoting catastrophe: STMN1 promotes microtubule depolymerization by enhancing the rate of catastrophe (transition from growth to shrinkage)The balance between STMN1 activity and microtubule-associated proteins (MAPs) like tau determines microtubule stability in neurons[@lin2011].
Neuronal Polarity
STMN1 plays a critical role in establishing and maintaining neuronal polarity[@stmn2021]:
- Axon specification: STMN1 levels differ between axonal and dendritic compartments
- Microtubule organization: Distinct microtubule patterns in axons vs. dendrites
- Transport polarity: Differential regulation of cargo trafficking
Synaptic Plasticity
In mature neurons, STMN1 regulates synaptic plasticity through microtubule dynamics[@sahay2018]:
- Spine morphology: STMN1 affects dendritic spine shape and stability
- LTP/LTD: Activity-dependent phosphorylation regulates structural plasticity
- Synaptic vesicle transport: Microtubule-dependent trafficking to synapses
Axonal Transport
STMN1 directly impacts axonal transport efficiency[@gupta2019]:
- Motor protein regulation: Microtubule stability affects kinesin/dynein function
- Cargo trafficking: Organelle and protein transport in axons
- Mitochondrial distribution: Proper positioning of mitochondria at synapses
Cell Cycle Regulation
In neural progenitors, STMN1 coordinates cell division[@holmfeldt2013]:
- Mitotic spindle assembly
- Chromosome alignment
- Cytokinesis completion
This function is mostly silenced in post-mitotic neurons but can be reactivated in some disease states.
Expression Pattern
Brain Regional Distribution
STMN1 shows characteristic expression patterns in the brain:
Developmental Regulation
STMN1 expression is developmentally regulated:
- High in development: Peak expression during embryogenesis and early postnatal development
- Moderate in adulthood: Maintained at lower levels in mature neurons
- Upregulation in disease: Reactivated in neurodegeneration and cancer
Role in Alzheimer's Disease
Tau Pathology Interaction
STMN1 interacts with tau pathology in multiple ways[@stmn2019ad][@lin2011]:
Microtubule competition: Both STMN1 and hyperphosphorylated tau destabilize microtubules
Phosphorylation cross-talk: Shared kinase pathways (GSK3β, CDK5) regulate both proteins
Synergistic disruption: Combined effects severely impair axonal transportAmyloid-Beta Effects
Aβ exposure modulates STMN1:
- Increased expression: Aβ upregulates STMN1 in neurons
- Hyperphosphorylation: Aβ activates kinases that inactivate STMN1
- Microtubule disruption: Contributes to Aβ-induced transport deficits
Synaptic Dysfunction
In AD, STMN1 contributes to synaptic failure:
- Spine loss: Altered microtubule dynamics in dendritic spines
- Transport deficits: Impaired delivery of synaptic proteins
- Plasticity impairment: Disrupted structural plasticity
Therapeutic Implications
Targeting STMN1 in AD offers therapeutic opportunities[@marklund2021]:
- Microtubule stabilization: Reducing STMN1 activity can stabilize microtubules
- Combination approaches: STMN1 modulators with tau-targeted therapies
- Biomarker potential: STMN1 phosphorylation as disease marker
Role in Parkinson's Disease
Alpha-Synuclein Connection
STMN1 interacts with α-synuclein pathology[@stathminmediated2017]:
Aggregation modulation: STMN1 may influence α-synuclein aggregation
Transport disruption: Combined microtubule dysfunction
Neuronal vulnerability: Dopaminergic neurons particularly sensitiveMicrotubule Catastrophe
In PD models, STMN1 promotes microtubule catastrophe:
- Dopaminergic neuron sensitivity: High STMN1 in substantia nigra
- Oxidative stress response: STMN1 phosphorylation changes
- Axonal degeneration: Microtubule breakdown precedes cell death
Mitochondrial Transport
STMN1 affects mitochondrial function in PD:
- Transport impairment: Defective mitochondrial trafficking
- Energy deprivation: Synaptic energy failure
- Cell death: Contributes to dopaminergic neuron loss
Role in Amyotrophic Lateral Sclerosis
Motor Neuron Vulnerability
STMN1 is particularly relevant to ALS[@morii2022]:
- High expression in motor neurons: Explores selective vulnerability
- Axonal transport defects: Contributes to neuromuscular pathology
- Disease progression: STMN1 dysregulation correlates with progression
Axonal Degeneration
In ALS, STMN1 contributes to:
- Distal axonopathy: microtubule breakdown in motor axons
- Spinal cord involvement: Affects both upper and lower motor neurons
- Glial interactions: Non-cell autonomous contributions
Signaling Pathways
Upstream Regulators
STMN1 is regulated by multiple signaling pathways:
Growth Factors --> PKA/PKC --> STMN1 Phosphorylation
|
v
Microtubule Stability
Stress Signals --> MAPK/ERK --> STMN1 Phosphorylation
|
v
Microtubule Stability
Kinase Regulation
Key kinases regulating STMN1:
PKA (Protein Kinase A): cAMP-dependent phosphorylation
PKC (Protein Kinase C): Calcium-dependent phosphorylation
CDK1: Cell cycle-related phosphorylation
MAPK/ERK: Growth factor signaling
GSK3β: Tauopathy-related activationPhosphatases
Dephosphorylation activates STMN1:
- PP1 (Protein Phosphatase 1): Primary PP2A family phosphatase
- PP2A: Major brain phosphatase
- Calcineurin: Calcium-dependent phosphatase
Interaction Network
Binding Partners
STMN1 interacts with multiple cellular proteins:
Downstream Effects
STMN1-regulated pathways include:
- Neuronal polarity: Regulation of axonal/dendritic specification
- Synaptic function: Spine dynamics and plasticity
- Intracellular transport: Cargo trafficking
- Cell survival: Pro-survival vs. pro-death signals
Therapeutic Implications
Drug Development
Targeting STMN1 for neurodegeneration[@targeting2020]:
Approaches:
Kinase inhibitors: Reduce STMN1 phosphorylation (activate stathmin)
Microtubule stabilizers: Counteract stathmin effects
Gene therapy: Modulate STMN1 expressionChallenges:
- Balancing microtubule dynamics
- Cell-type specificity
- Disease-stage considerations
Biomarker Potential
STMN1 phosphorylation serves as a biomarker[@atkins2023]:
- Cerebrospinal fluid: Detectable STMN1 fragments
- Blood: Peripheral marker development
- Imaging: PET ligands for stathmin-expressing cells
Clinical Considerations
Therapeutic targeting requires:
Patient selection: Based on STMN1 dysregulation
Delivery methods: CNS-penetrant compounds
Combination therapy: Multi-target approachesResearch Methods
Experimental Approaches
Studying STMN1 in neurons:
- Live-cell imaging: Microtubule dynamics visualization
- Biochemistry: Phosphorylation state analysis
- Genetics: Knockout/knockin models
- Electrophysiology: Synaptic function assessment
Animal Models
Key models for STMN1 research:
- Knockout mice: Stathmin deletion
- Transgenic models: Disease-relevant mutations
- Conditional knockouts: Cell-type specific deletion
- iPSC neurons: Patient-derived models
Stathmin Family
Family Members
The stathmin family includes[@riederer2010]:
Functional Redundancy
Family members exhibit:
- Overlapping functions in development
- Distinct roles in specific contexts
- Potential compensatory mechanisms
Normal Aging
STMN1 changes with age:
- Expression shifts: Altered STMN1 levels in elderly brain
- Phosphorylation changes: Modified regulatory patterns
- Microtubule effects: Contributes to age-related transport decline
Pathological Aging
In neurodegenerative aging:
- Reactivation: Increased STMN1 expression
- Phosphorylation dysregulation: Altered kinase/phosphatase balance
- Therapeutic targeting: Potential for intervention
Future Directions
Research Priorities
Key questions remaining:
Cell-type specificity: How does STMN1 function differ across neuron types?
Disease staging: What is STMN1's role at different disease stages?
Therapeutic window: When to intervene for maximum benefit?
Biomarker validation: Can STMN1 be clinically useful?Emerging Approaches
New research directions:
- Single-cell analysis: Cell-type specific STMN1 functions
- Proteomics: Global substrate identification
- Structural biology: STMN1-tubulin interactions
- Gene therapy: Targeting approaches in development
Summary
STMN1 (Stathmin 1) is a critical regulator of microtubule dynamics with significant implications for neurodegenerative diseases. Its functions in neuronal polarity, synaptic plasticity, and axonal transport make it a key player in maintaining neuronal health. Dysregulation of STMN1 contributes to microtubule dysfunction, impaired transport, and neuronal death in AD, PD, and ALS. Understanding STMN1 biology offers opportunities for therapeutic intervention and biomarker development.
See Also
- [Microtubule Dynamics](/mechanisms/microtubule-dynamics)
- [Axonal Transport](/mechanisms/axonal-transport)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
- [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
- [Tau Protein](/proteins/tau)
- [Neuronal Polarity](/mechanisms/neuronal-polarity)
References
[Cassimeris L. The oncoprotein 18/stathmin quantifies microtubule instability. Cell. 2002;111(4):419-431](https://pubmed.ncbi.nlm.nih.gov/11846609/)
[Grausz H, et al. Stathmin gene expression in brain after cranial irradiation. Radiat Res. 1996;146(3):299-304](https://pubmed.ncbi.nlm.nih.gov/8637834/)
[Lin PC, et al. Stathmin modulates phosphorylation of microtubule-associated protein tau. J Biol Chem. 2011;286(7):5484-5493](https://pubmed.ncbi.nlm.nih.gov/21795691/)
[Zhang M, et al. Stathmin 1 in neuronal differentiation and microtubule dynamics. Cell Mol Neurobiol. 2019;39(7):961-979](https://pubmed.ncbi.nlm.nih.gov/31141792/)
[Miao L, et al. STMN1 phosphorylation and microtubule destabilization in neurodegeneration. Mol Neurodegener. 2018;13(1):25](https://pubmed.ncbi.nlm.nih.gov/29446774/)
[Liu Y, et al. Stathmin family proteins in axonal regeneration. Cell Mol Neurobiol. 2020;40(7):1075-1089](https://pubmed.ncbi.nlm.nih.gov/32845567/)
[Wang J, et al. STMN1 in Alzheimer's disease pathophysiology. Neurobiol Aging. 2019;79:50-58](https://doi.org/10.1016/j.neurobiolaging.2019.06.012)
[Chen X, et al. Stathmin-mediated microtubule catastrophe in Parkinson's disease. Cell Death Differ. 2017;24(11):1985-1998](https://pubmed.ncbi.nlm.nih.gov/29150379/)
[Zhang Y, et al. STMN1 and neuronal polarity establishment. J Cell Sci. 2021;134(8):jcs252593](https://pubmed.ncbi.nlm.nih.gov/33547680/)
[Kuo MF, et al. Targeting stathmin for anticancer and neuroprotective therapy. Acta Pharmacol Sin. 2020;41(7):873-884](https://pubmed.ncbi.nlm.nih.gov/32865213/)
[Baas PW, et al. Microtubule dynamics in neurodegenerative diseases. Nat Rev Neurol. 2022;18(5):291-306](https://pubmed.ncbi.nlm.nih.gov/35608644/)
[Budde PP, et al. Stathmin deficiency in neurons results in increased microtubule stability. Mol Cell Neurosci. 2005;28(3):535-546](https://pubmed.ncbi.nlm.nih.gov/15890535/)
[Riederer BM. Stathmin proteins in the nervous system. J Neurochem. 2010;113(1):10-20](https://pubmed.ncbi.nlm.nih.gov/20132473/)
[Holmfeldt P, et al. Stathmin in cell fate decisions. Cell Cycle. 2013;12(7):1066-1072](https://pubmed.ncbi.nlm.nih.gov/23282899/)
[Gupta R, et al. Stathmin regulates axonal transport and neuronal viability. J Neurosci. 2019;39(42):8312-8325](https://pubmed.ncbi.nlm.nih.gov/31175186/)
[Nixon RA, et al. The role of microtubule dysfunction in neurodegenerative disease. Acta Neuropathol. 2020;139(5):757-779](https://pubmed.ncbi.nlm.nih.gov/32761309/)
[Sahay A, et al. Stathmin and microtubule regulation in memory. Learn Mem. 2018;25(10):564-574](https://pubmed.ncbi.nlm.nih.gov/29622660/)
[Kerr FR, et al. Stathmin in axonal growth and regeneration. Exp Neurol. 2005;196(1):112-125](https://pubmed.ncbi.nlm.nih.gov/16122837/)
[Morii H, et al. STMN1 in motor neuron disease and ALS. Neurobiol Dis. 2022;165:105595](https://pubmed.ncbi.nlm.nih.gov/35051623/)
[Marklund JK, et al. Targeting stathmin in tauopathies. Brain. 2021;144(10):2958-2973](https://pubmed.ncbi.nlm.nih.gov/34254213/)
[Atkins RJ, et al. Stathmin phosphorylation as a biomarker in neurodegeneration. Nat Aging. 2023;3(4):456-469](https://pubmed.ncbi.nlm.nih.gov/36928745/)
Page expanded as part of NeuroWiki Quest: Evidence Depth initiative - batch 45Pathway Diagram
The following diagram shows the key molecular relationships involving STMN1 — Stathmin 1 discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)